Earnings Ahead

ISRG - Intuitive Surgical, Inc.

330.02 4.86 1.5

Intuitive Surgical, Inc.

Intuitive Surgical, Inc.

About

Profile

Intuitive Surgical, Inc. (Nasdaq:ISRG), headquartered in Sunnyvale, Calif., is the pioneer and a global technology leader in robotic-assisted, minimally invasive surgery. Intuitive develops, manufactures and markets the da Vinci surgical system.


Headquarters

Sunnyvale, California, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

ISRG



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Intutitive Surgical rises 6% following quarterly results
  • Intuitive Surgical Non-GAAP EPS of $1.60 beats by $0.11, revenue of $1.93B beats by $30M
  • Johnson & Johnson’s MedTech performance augurs well for industry: analysts
  • 4 bull stocks and 2 bear stocks by BofA
  • Intuitive Surgical set to report Q4 earnings day after hitting new 52-week high
  • Anti-obesity meds can expand the market for weight loss surgery: Bernstein
  • Intuitive Surgical stock hits 52-week high
  • ConMed slips amid concerns over Intuitive Surgical’s plans for da Vinci
  • Citi’s top 20 large-cap recommendation list
  • Baird bullish on medtech in 2024, but sees weakness in dental market
  • Intuitive stock jumps 9% in wake of preliminary sales report, outlook
  • Biggest stock movers today: Virgin Galactic, Amarin, Alcon, Intuitive Surgical, and more
  • Intuitive prelim results beat as surgical procedures recover, stock +5% after hours
  • Top 10 stock ideas for 2024 Q1 - BofA
  • Goldman Sachs top 30 mutual fund overweight holdings
  • Jefferies U.S. quant portfolio - ROIC stars and high yield
  • M&A, GLP-1s to dominate healthcare themes in 2024 as COVID fades: survey
  • HSBC starts Intuitive Surgical at buy, cites recurring revenue
  • MedTech stocks gain after Novo Nordisk data for weight loss therapy
  • Boston Sci, Stryker, Dexcom, Shockwave are BoA's top medtech picks

Earnings History

Date EPS / Forecast Revenue / Forecast
January 20, 2022 1.3 / 1.28 1.55B / 1.51B Beat!
October 19, 2021 1.19 / 1.17 1.4B / 1.38B Beat!
July 20, 2021 1.31 / 3.07 1.46B / 1.27B Beat!
April 20, 2021 3.52 / 2.64 1.29B / 1.11B Beat!
January 21, 2021 3.58 / 3.12 1.33B / 1.25B Beat!
October 15, 2020 2.77 / 2.06 1.08B / 970.98M
July 21, 2020 1.11 / 0.53 852.1M / 671.39M Beat!
April 16, 2020 2.69 / 2.64 1.1B / 1.05B Beat!
January 23, 2020 3.48 / 3.38 1.28B / 1.23B Beat!
October 17, 2019 3.43 / 2.99 1.13B / 1.07B Beat!
July 18, 2019 3.25 / 2.87 1.1B / 1.03B Beat!
April 18, 2019 2.61 / 2.7 973.7M / 975.29M
January 24, 2019 2.96 / 3.07 1.05B / 1.04B Beat!
October 18, 2018 2.83 / 2.66 920.9M / 916.69M Beat!
July 19, 2018 2.76 / 2.5 909.3M / 876.32M Beat!
April 17, 2018 2.44 / 2.07 847.5M / 776.61M Beat!